RecruitingNot applicableNCT07224308
Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm
Studying Ataxia-telangiectasia variant
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Levine Center for Plastic Surgery
- Principal Investigator
- Jennifer Levine, MDPrincipal Investigator
- Intervention
- Ultherapy Prime(device)
- Enrollment
- 20 enrolled
- Eligibility
- 25-65 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- The Levine Center for Plastic Surgery, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07224308 on ClinicalTrials.govOther trials for Ataxia-telangiectasia variant
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06033092Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTionEuropean Institute of Oncology
- ACTIVE NOT RECRUITINGPHASE2NCT04030559Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsMarc Dall'Era, MD
- RECRUITINGNCT05129605Prostate Cancer Genetic Risk Evaluation and Screening StudyMassachusetts General Hospital